Clinical trial
A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai…
NCT00476424 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Completed
Key facts
| NCT number | NCT00476424 |
|---|---|
| Title | A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects |
| Official title | A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects |
| Lead sponsor | The HIV Netherlands Australia Thailand Research Collaboration, Other |
| Collaborators | Ministry of Education, Thailand |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | efavirenz |
| Enrollment | 28 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | May 22, 2007 |
| Last update posted | Jul 17, 2020 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: